Q-linea AB (publ) (3F8.F)

0.1606 -0.0008 (-0.50%) As of 08:05AM CEST. Market open.

Q-linea AB (publ)

Dag Hammarskjölds väg 52 A
Uppsala 752 37
Sweden
46 1 84 44 36 10
https://qlinea.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 127

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Stuart Gander	Chief Executive Officer	N/A	N/A	1978
Mr. Christer Samuelsson	CFO & IR	N/A	N/A	1962
Mr. Henrik Jacobson	Chief Operating Officer	N/A	N/A	1969
Ms. Ulrika Stolpe	HR Manager	N/A	N/A	1967
Ms. Tiziana Di Martino	Chief Medical Officer	N/A	N/A	1976
Mr. Thomas Fritz	Chief Commercial Officer	N/A	N/A	1964
Mr. Anders Ljunggren	Managing Director	N/A	N/A	1981
Ms. Victoria Lerneryd	Manager of QA/RA	N/A	N/A	1984

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. It offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. The company serves healthcare providers. Q-linea AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden.

Corporate governance

Q-linea AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.